Vanguard Group
ANVS icon

Vanguard Group’s Annovis Bio ANVS Stock Holding History

Vanguard Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.19M Buy
923,201
+185,198
+25% +$557K ﹤0.01% 3414
2025
Q3 		$1.53M Buy
738,003
+41,239
+6% +$103K ﹤0.01% 3660
2025
Q2 		$1.51M Buy
696,764
+48,844
+8% +$96.4K ﹤0.01% 3625
2025
Q1 		$972K Buy
647,920
+181,643
+39% +$556K ﹤0.01% 3718
2024
Q4 		$2.35M Buy
466,277
+86,022
+23% +$623K ﹤0.01% 3516
2024
Q3 		$3.06M Buy
380,255
+18,901
+5% +$177K ﹤0.01% 3433
2024
Q2 		$2.08M Buy
361,354
+3,412
+1% +$27.7K ﹤0.01% 3543
2024
Q1 		$4.26M Buy
357,942
+20,588
+6% +$225K ﹤0.01% 3358
2023
Q4 		$6.31M Buy
337,354
+78,824
+30% +$699K ﹤0.01% 3192
2023
Q3 		$2.45M Buy
258,530
+6,500
+3% +$80.4K ﹤0.01% 3515
2023
Q2 		$3.6M Buy
252,030
+9,459
+4% +$134K ﹤0.01% 3456
2023
Q1 		$3.74M Hold
242,571
– – ﹤0.01% 3439
2022
Q4 		$3.26M Buy
242,571
+110
+0% +$1.38K ﹤0.01% 3482
2022
Q3 		$3.32M Hold
242,461
– – ﹤0.01% 3529
2022
Q2 		$2.75M Hold
242,461
– – ﹤0.01% 3672
2022
Q1 		$3.24M Buy
242,461
+13,306
+6% +$192K ﹤0.01% 3736
2021
Q4 		$4.03M Sell
229,155
-329
-0.1% -$8.48K ﹤0.01% 3728
2021
Q3 		$7.29M Buy
229,484
+31
+0% +$1.78K ﹤0.01% 3427
2021
Q2 		$19.6M Buy
229,453
+82,452
+56% +$3.81M ﹤0.01% 2859
2021
Q1 		$4.1M Buy
+147,001
New +$3.15M ﹤0.01% 3629

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group's ANVS Position: Q4 2025 in Review

Vanguard Group increased its Annovis Bio (ANVS) stake by 25% in Q4 2025, buying an estimated $557K and bringing the position to 923,201 shares worth $3.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3414.

Vanguard Group first reported a position in ANVS in Q1 2021 and has held it in 20 quarters since. The position peaked at $19.6M in Q2 2021. 53 funds tracked by Wall St. Rank hold ANVS as of Q4 2025.

  • Vanguard Group held 923,201 shares of Annovis Bio worth $3.19M as of Q4 2025.
  • Vanguard Group bought 185,198 Annovis Bio shares in Q4 2025, an estimated $557K.
  • Annovis Bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3414 holding.
  • Vanguard Group first reported a position in Annovis Bio in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's Annovis Bio position peaked at $19.6M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Annovis Bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.